| Oct 19 |
Speculating On Innovation: How Renaissance IPO ETF Is Beating ARKK
|
| Oct 17 |
Curanex, botanical drug developer, files for $10M IPO
|
| Oct 14 |
IPO Roundup: Drugs Made in America Acquisition, FBS Global and more
|
| Oct 11 |
Upstream Bio stock rallies 32% following upsized $255M IPO
|
| Oct 11 |
CeriBell, EEG developer, sees stock rally 35% following $180M IPO
|
| Oct 11 |
CAMP4 stock edges up 2% following $75M IPO
|
| Oct 8 |
Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs
|
| Oct 7 |
IPO Roundup: KinderCare Learnings, Moove and more
|
| Oct 3 |
Septerna, hypoparathyroidism drug developer, files for $100M IPO
|
| Sep 30 |
IPO Roundup: FrontView REIT, StandardAero and more
|
